A5015745084- Cardiac Imaging and Diagnostics
- Cardiac Arrhythmias and Treatments
- Acute Myocardial Infarction Research
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiovascular Issues in Pregnancy
- Heart Failure Treatment and Management
- Coronary Artery Anomalies
- Cardiomyopathy and Myosin Studies
- Coronary Interventions and Diagnostics
- Parathyroid Disorders and Treatments
- Pericarditis and Cardiac Tamponade
- Cardiovascular Disease and Adiposity
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac tumors and thrombi
- Kawasaki Disease and Coronary Complications
- Cardiac, Anesthesia and Surgical Outcomes
- Mechanical Circulatory Support Devices
- Cerebrovascular and Carotid Artery Diseases
- Viral Infections and Immunology Research
Marche Polytechnic University
2017-2025
Università Cattolica del Sacro Cuore
2021-2025
Ospedali Riuniti Umberto I
2021-2024
Ospedali Riuniti di Ancona
2017-2024
Agostino Gemelli University Polyclinic
2021-2023
Azienda Ospedaliero Universitaria Ospedali Riuniti
2018-2023
Associazione Nazionale Medici Cardiologi Ospedalieri
2023
Istituti di Ricovero e Cura a Carattere Scientifico
2021-2022
KLE Society Hospital
2018
Sir Ganga Ram Hospital
2018
Epidemiology of wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) remains poorly defined. A better characterization pathways leading to ATTRwt-CA diagnosis is key importance, and potentially informative disease course prognosis. The aim this study was describe the characteristics contemporary diagnosis, their potential association with survival.This a retrospective patients diagnosed at 17 Italian referral centres for CA. Patients were categorized into different 'pathways' according...
To evaluate the trend of prescription four foundational therapies, and their impact on 30-day urgent re-admissions all-cause death in patients with heart failure reduced ejection fraction (HFrEF) following an acute decompensation event. Retrospective. One tertiary referral centre. 999 consecutively admitted a primary diagnosis HFrEF between January 2020 June 2023 were identified through validated, high-performance technology infrastructure based artificial intelligence. The entire cohort was...
Background Guidelines recommend using multiple drugs in patients with heart failure (HF) reduced ejection fraction, but there is a paucity of real-world data on the simultaneous initiation 4 pharmacological pillars at discharge after decompensation event. Methods and Results A retrospective mart, including diagnosed HF, was implemented. Consecutively admitted HF fraction were selected through an automated approach categorized according to number/type treatments prescribed discharge. The...
The use of beta-blocker therapy in cardiac amyloidosis (CA) is debated. We aimed at describing patterns prescription through a nationwide survey.From 11 referral centres, we retrospectively collected data CA patients with first evaluation after 2016 (n = 642). Clinical characteristics and last were collected, focus on medical therapy. For whom was started, stopped, or continued between evaluation, the main reason for management requested. Median age study population 77 years; 81% men....
Messenger RNA (mRNA) coronavirus disease of 2019 (COVID-19) vaccines have been recently associated with acute myocarditis, predominantly in healthy young males. Out 231,989 administrated our region (Marche, Italy), we report a case series six patients (four males and two females, 16.5 years old (Q1, Q3: 15, 18)) that experienced mRNA-COVID-19-vaccines side effects. All were hospitalized due to fever troponins elevation following the second dose an mRNA-based COVID-19 vaccine. Cardiovascular...
Heart failure (HF) is a multifaceted clinical syndrome characterized by different etiologies, risk factors, comorbidities, and heterogeneous course. The current model, based on data from trials, limited the biases related to highly-selected sample in protected environment, constraining applicability of evidence real-world scenario. If properly leveraged, enormous amount may have groundbreaking impact care pathways. We present, here, development an HF DataMart framework for management...
To analyze the characteristics and prognosis of a contemporary cohort patients with myocardial infarction non-obstructed coronaries (MINOCA) were referred for cardiac magnetic resonance (CMR) imaging, focusing on late gadolinium enhancement (LGE) patterns.We retrospectively examined prospectively followed up 135 (49 ± 21 years old, 48% female) undergoing CMR imaging due to MINOCA diagnosis from 2014 2016. We grouped analyzed sample according ischemic (focal or transmural) non-ischemic LGE...
The term "MINOCA" refers to myocardial infarction with non-obstructed coronary arteries and has been used define acute no angiographic evidence of significant epicardial artery stenosis. Patients MINOCA represent a rather heterogeneous group syndrome, this may account for the wide variation in incidence different studies. Several pathogenic mechanisms have suggested underlie MINOCA, but condition continues diagnostic therapeutic challenge cardiologist. Therefore, an adequate assessment,...